Profile insights Find out how your skills align with the job description Skills Do you have experience in Organizational skills? Education Do you have a… Click here to view original postBioLegend, Inc. (a division of Revvity, Inc.) develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Packaging? Education Do you have a High… Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Communication skills? Education Do you have a… Click here to view original postWe are seeking a dynamic and experienced Talent Acquisition Specialist to join our team. The incumbent will be… Click here to view original postConference Call and Webcast Scheduled for Thursday, February 6 SAN DIEGO, Jan. 30, 2025 /PRNewswire/ –Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2024 financial results conference [...]Groundbreaking Event Convenes at Sharp HealthCare’s Newly Opened Spatial Computing Center of Excellence SAN DIEGO, Jan. 30, 2025 /PRNewswire/ — Sharp HealthCare today kicked off the Inaugural Spatial Computing Health Care Summit, where more than [...]Extended Deadline: Fri 2/14/2025 UC San Diego values equity, diversity, and inclusion. If you are interested in… Click here to view original postA group of UC San Diego researchers and staff gathered for one of the first events in an Office of Research and Innovation series designed to help researchers on campus increase funding for their work [...]Filing Deadline: Wed 2/12/2025 UC San Diego values equity, diversity, and inclusion. If you are interested in… Click here to view original postSan Diego, CA General & Administrative – Finance / Non-exempt Full-time… Click here to view original postConference Call Scheduled for Wednesday, February 5 at 4:30 p.m. Eastern Time SAN DIEGO, Jan. 29, 2025 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel [...]Our mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities… Click here to view original postAccording to a new study from researchers at the University of California San Diego’s Center for Healthy Eating and Activity Research (CHEAR), self-guided family therapy for obesity could work just as well as traditional approaches [...]SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, is pleased to invite investors to a webinar [...]Two graduate design students in the Department of Theatre and Dance invited us behind the scenes as they created costumes for two recent plays that centered on power dynamics and societal expectations. Discover the research, [...]First Patient enrolled and treated at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-PD-1 Antibodies SAN DIEGO, Jan. 29, 2025 /PRNewswire/ — Aethlon [...]SAN DIEGO, Jan. 29, 2025 /PRNewswire/ — Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January [...]Discover a career with real meaning. One that offers the opportunity to showcase your talents, achieve measurable success and… Click here to view original postSartorius is seeking a dynamic entrepreneurially spirited Account Manager to be based remotely in the Southern California/Los Angeles territory…. Click here to view original postProfile insights Find out how your skills align with the job description Skills Do you have experience in Drug discovery? Education Do you have a… Click here to view original postSAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that its ending cash balance at [...]Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled 2025 during his presentation at the recent 43rd Annual J.P. Morgan Healthcare Conference. The designation [...]